Symposiums

Experts discuss insomnia disorder during menopause, health risks, diagnostic gaps, and emerging treatments including orexin receptor…

Menopause-related symptoms, including vasomotor symptoms and sleep disturbances, are common and have a substantial impact on quality of…

Updated clinical data from the Phase III JUPITER-02 and JUPITER-06 trials of the anti-PD1 antibody toripalimab in NPC and OSCC, presented…

Vasoplegia is defined as sustained low systemic vascular resistance in the context of a normal or high cardiac index, leading to…

Cutaneous T cell lymphomas (CTCL) are a heterogenous group of rare malignancies primarily involving the skin, of which mycosis fungoides…

The ‘Multi-immune modulation: a paradigm shift in understanding and treating immune thrombocytopenia (ITP) and warm autoimmune…

JCV is a DNA polyomavirus and the primary aetiological agent of PML. Most adults carry JCV in its latent form, but the virus can become…

Zovegalisib (RLY-2608) is the first pan-mutant-selective PI3Kα inhibitor, binding a novel allosteric site distinct from approved…

These symposia were held during the European Respiratory Society (ERS) Congress 2025. The first symposium focused on the importance of…

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim of the…

A summary of new data on tralokinumab in atopic dermatitis, presented at conferences/symposia held between September and October 2024.

During this symposium, leading international epileptologists discussed the key challenges and opportunities that currently exist within…

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST 2025…

Convened during the European Respiratory Society (ERS) Congress 2025, this symposium provided an in-depth discussion of the…

Experts discuss individualising menopausal hormone therapy and the impact of this therapy on long-term health in menopausal females…

Becker is a serious, progressive neuromuscular condition that is X-linked, affecting approximately one in 18,000 male births.1,2 It is…

Renal denervation (RDN) is a minimally invasive procedure used as an adjunctive treatment for individuals with resistant hypertension when…

Subcutaneous administration of natalizumab provides similar real-world effectiveness to intravenous administration, providing a convenient…

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor of…

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy regimens to…

During this symposium at the European Society of Medical Oncology (ESMO) Congress 2025, leading experts in oncology and nutrition…

Anal and colorectal cancers are complex gastrointestinal malignancies that continue to pose therapeutic and diagnostic challenges…

Karine Lacombe, Professor at Sorbonne Université, Paris, France, set the scene by outlining the current trajectory of the HIV epidemic and…

This article reviews data on the efficacy and safety of nerandomilast in IPF and PPF, including the latest updates presented at ATS 2025…

One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, which can…

Adequate management of COPD is important because hospitalisation for an acute exacerbation of COPD (AECOPD) is associated with…

The findings of three retrospective studies provide valuable insights into the burden of bronchiectasis across different healthcare…

AD is one of the most common inflammatory skin conditions,1-4 with global prevalence estimated to be 2.6% (adults: approximately 2.0%;…

Zink opened the session by recapping key efficacy data for ruxolitinib cream in non-segmental vitiligo from the TRuE-V1/2 registration…

Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent data from…

This symposium at ERA 2025 explored the evolving treatment landscape in immunoglobulin A nephropathy (IgAN) and novel, targeted therapies…

According to USA data, around 15% of patients with endometrial cancer (EC) have advanced disease at diagnosis, which is…

BK is a short-lived effector molecule that belongs to the peptide family of kinins and plays a crucial role in inflammation. It was first…

This symposium review article discusses the latest European guidelines for the diagnosis and treatment of cow’s milk allergy in young…

The ‘Mastering the Relapsed Refractory Multiple Myeloma (RRMM) Treatment Landscape: Removing Barriers and Unleashing the Potential of…

At this EAACI 2025 symposium, experts discuss CRSwNP and Severe Asthma, the associated patient burden, and explore the role of IL-5…

Exploration of key data on chronic inflammatory demyelinating polyneuropathy (CIDP) presented at EHA 2025. Post-hoc analysis of the ADHERE…

Uterine fibroids are benign smooth muscle tumours occurring in the uterus. Although some women are able to live with uterine…

This review article explores key research highlights and new data on CLL presented at EHA 2025, considering how the latest clinical…

Hereditary angioedema (HAE) attacks are unpredictable and can be debilitating and potentially life-threatening. The burden of HAE disease…

Hereditary angioedema (HAE) is a rare genetic condition that causes unpredictable, recurrent episodes of swelling, particularly affecting…

This symposium explored issues, guidance, and benefits associated with bi-directional HCP-patient communication, using hereditary angioedema consultations as an example.

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of gonadotropin…

Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…

CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the 21st…

This article has now been retracted and a retraction statement has been published.